ENGNW · enGene Therapeutics Inc. · Shareholders & Ownership
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Codification ("ASC") 205-40, Going Concern, the Company has evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued. As of the issuance date of these consolidated financial statements, the Company expects that its existing cash, cash equivalents and marketable securities as of April 30, 2026 will be sufficient to fund its operating expenses and debt obligations requirements for at least the next 12 months.”View the 10-Q filed Jun 15, 2026
Every disclosed holder of ENGNW in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns ENGNW
13F quarter Jun 30, 2026; this listing alone: insiders and shares outstanding are issuer-wide, so they are left outNo chart: shares outstanding cannot be set against these holders.
| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 2,461,328 | — |
| Insiders (Forms 3, 4, 5) | 0 | — |
| 13D/G-only blocks | 0 | — |
| Registered funds (N-PORT, not summed) | 0 | — |
% Out is unavailable: shares outstanding is an issuer-wide count, not one listing's.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of ENGNW
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
BVF INC/IL
13F
CIK 1056807 · Unknown · Jun 30, 2026
|
945,402 | ||
| 2 |
Blue Owl Capital Holdings LP
13F
CIK 1858703 · Investment adviser · Jun 30, 2026
|
511,177 | ||
| 3 |
Caption Management, LLC
13F
CIK 1706766 · Registered investment adviser · Jun 30, 2026
|
333,675 | ||
| 4 |
LMR Partners LLP
13F
CIK 1578621 · Exempt reporting adviser · Jun 30, 2026
|
309,763 | ||
| 5 |
ARISTEIA CAPITAL, L.L.C.
13F
CIK 1080171 · Registered investment adviser · Jun 30, 2026
|
197,678 | ||
| 6 |
D. E. Shaw & Co., Inc.
13F
CIK 1009207 · Unknown · Jun 30, 2026
|
104,622 | ||
| 7 |
TORONTO DOMINION BANK
13F
CIK 947263 · Bank · Jun 30, 2026
|
31,545 | ||
| 8 |
CSS LLC/IL
13F
CIK 1103646 · Unknown · Jun 30, 2026
|
16,895 | ||
| 9 |
StoneX Group Inc.
13F
CIK 913760 · Unknown · Jun 30, 2026
|
10,371 | ||
| 10 |
Clear Street Group Inc.
13F
CIK 1881567 · Unknown · Jun 30, 2026
|
200 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.